Identification of STAT3 as a specific substrate of breast tumor kinase
about
In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissuesSignal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenograftsProtein-tyrosine kinase 6 promotes peripheral adhesion complex formation and cell migration by phosphorylating p130 CRK-associated substratePTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBMThe associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.Brk/PTK6 signaling in normal and cancer cell models.STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress.Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRKDynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-β1.Evolution of breast cancer therapeutics: Breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapyMechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosisSuppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells.BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathwayPTK6 promotes cancer migration and invasion in pancreatic cancer cells dependent on ERK signaling.Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFRProtein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin.Tracking STAT nuclear traffic.Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancerPrognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models.Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer.Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins.Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo.Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
P2860
Q24294917-0D89FDB2-D0FF-4283-B797-7964F2ADE051Q24300274-44E0082F-CC36-4EEF-A057-5CFD8900F712Q27334603-7F8F8AAF-37E8-4885-AE95-A55F72B85DD8Q28115210-60F4D01C-4657-48CD-9047-9F1DBFB81736Q28116075-75579192-D192-4093-B0E1-0D4FAAC228EAQ30009178-811227D4-E8E7-4291-9888-8E5B1BAE13CDQ33543078-2FD2E91C-F6E1-429D-973D-E68386547656Q33578030-3458573E-DBA6-40B3-BCE5-78733E09A3C5Q33598866-EA6A17DF-F5A0-425E-B9B5-3F4354D3DCF3Q33690176-E74464EB-7D0B-4782-9A74-AFF3D5E11DA5Q33733773-B35E7717-03FD-4829-8B1E-150D84D8965BQ33912469-0A74EA00-F9FD-464B-8397-0015F4926589Q33916478-FB9FB0FA-5899-4C80-83E3-8A77B4B15722Q34023653-A09E1CC0-1171-45A5-B6B9-C8F4B8FDB7B1Q34085432-199C71A5-DD4A-4A0C-B7DA-545130E945F0Q34173535-03B749BA-8EB4-408D-A3EB-2DDA56E4F9D1Q34352081-1635FF72-2B41-407E-89DE-0A041D688B69Q34536056-39D01C33-8B6F-4FC3-B558-EFBD11456515Q34543450-CD4DF9BB-4443-4B9E-B790-15441AB80DE6Q34543476-A30E530C-536F-41CF-9EF9-A525659B4A8CQ34659926-E1756DA0-A58D-4638-9F6C-A969080ED3E5Q35093544-8A62482B-C020-4807-AAB6-A6762C655DC3Q35154495-B7D5CDD0-185A-4CFF-93D9-64AC4238451BQ35161670-DFCF637F-A6CE-4E70-9946-90336204FB0EQ35683544-D0C511C5-9F0F-42C3-A30D-070FA6AA06FDQ35834635-B1CA1334-003D-471E-9EB4-76DA3E6DE3CFQ35888553-1ECC8CE5-215C-4E5F-9F1B-8D408F04E96DQ36022273-5B70F96C-1822-4B7A-910D-0D1B2DF7ED85Q36033134-0C13EBD2-88E4-406B-A6B6-7AA8770AC425Q36054456-09EEEC5E-C3B7-45EA-8275-F1DA75B3A199Q36547212-2F7D8A5D-5BB8-4AF4-8B96-CA69B63631B2Q36677706-9405CC06-82C7-4BAE-99C2-22D637BD65C6Q36884986-A158E019-D45A-49E0-B4B9-BCFBBA07C626Q36935997-03043EB7-4AF3-4FA5-BB37-D76954F852A4Q37017273-7D972BA4-9ACB-4D94-8055-5904665B7A75Q37614521-9DF2F5C9-D4B2-41E8-8FB9-CEE6780D2347Q38080556-56D2CB9F-157A-4AA9-AC43-63C80542A693Q38530632-9A4E47C2-9C1F-449F-A5C3-7B3F803EE8E2Q38954660-039B32BF-E036-4430-863A-D54D639BC69BQ39268132-9DF473EE-2A3C-4B08-A6E7-A0D13C4811EA
P2860
Identification of STAT3 as a specific substrate of breast tumor kinase
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of STAT3 as a specific substrate of breast tumor kinase
@ast
Identification of STAT3 as a specific substrate of breast tumor kinase
@en
Identification of STAT3 as a specific substrate of breast tumor kinase
@en-gb
Identification of STAT3 as a specific substrate of breast tumor kinase
@nl
type
label
Identification of STAT3 as a specific substrate of breast tumor kinase
@ast
Identification of STAT3 as a specific substrate of breast tumor kinase
@en
Identification of STAT3 as a specific substrate of breast tumor kinase
@en-gb
Identification of STAT3 as a specific substrate of breast tumor kinase
@nl
prefLabel
Identification of STAT3 as a specific substrate of breast tumor kinase
@ast
Identification of STAT3 as a specific substrate of breast tumor kinase
@en
Identification of STAT3 as a specific substrate of breast tumor kinase
@en-gb
Identification of STAT3 as a specific substrate of breast tumor kinase
@nl
P2093
P356
P1433
P1476
Identification of STAT3 as a specific substrate of breast tumor kinase
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1209501
P407
P577
2006-08-10T00:00:00Z
P5875
P6179
1007087562